P55 Hemolytic disease of newborn

Name of the Condition

• Common Name: Hemolytic disease of newborn
• Medical Term: Hemolytic disease of newborn

Summary

Hemolytic disease of newborn (HDN) is a condition where the newborn’s red blood cells are destroyed faster than they can be produced, often due to incompatibility between maternal and fetal blood. This can lead to anemia, jaundice, and other complications.

Causes

HDN occurs when maternal antibodies cross the placenta and attack fetal red blood cells. Common triggers include Rh incompatibility (Rh-negative mother carrying an Rh-positive fetus) or ABO blood group incompatibility. Other causes may involve minor blood group antigens or immune-mediated destruction.

Risk Factors

• Maternal blood type incompatibility with the fetus (e.g., Rh or ABO mismatch)
• Previous pregnancies with incompatible blood types
• Maternal exposure to fetal blood (e.g., during delivery or procedures)
• Family history of hemolytic disease in prior pregnancies

Symptoms

• Jaundice (yellowing of skin/eyes)
• Pallor or fatigue from anemia
• Enlarged liver or spleen
• Dark urine or pale stools
• In severe cases, hydrops fetalis (fluid buildup in tissues)

Diagnosis

Diagnosis involves blood tests to detect hemolysis, bilirubin levels, and antibody screening. Direct Coombs test identifies antibodies on fetal red blood cells, while bilirubin measurements assess severity. Prenatal testing may include maternal antibody titers or ultrasound for hydrops.

Treatment Options

• Phototherapy: Reduces bilirubin levels to prevent kernicterus.
• Exchange transfusion: Replaces the newborn’s blood in severe cases.
• Intravenous immunoglobulin (IVIG): May reduce antibody-mediated destruction.
• Supportive care: Monitoring for anemia or respiratory distress.

Prognosis and Follow-Up

With timely treatment, most newborns recover fully. Long-term follow-up monitors for anemia, jaundice recurrence, or developmental delays. Severe cases may require ongoing care for complications like kernicterus.

Complications

• Kernicterus (bilirubin-induced brain damage)
• Severe anemia leading to heart failure
• Hydrops fetalis (life-threatening fluid buildup)
• Long-term neurodevelopmental issues if untreated

Lifestyle & Prevention

• Prenatal Rh immunoglobulin (RhIg) for Rh-negative mothers to prevent sensitization.
• Blood type screening early in pregnancy.
• Monitoring for jaundice or anemia in newborns with risk factors.

When to Seek Professional Help

Seek immediate care if the newborn shows signs of jaundice (e.g., yellow skin, poor feeding) or lethargy. Prompt evaluation is critical to prevent severe complications.

Tips for Medical Coders

• Code P55 is used for hemolytic disease of newborn, including Rh or ABO incompatibility.
• Document maternal blood type, antibody status, and newborn symptoms (e.g., jaundice, anemia) to support coding.
• Specify if the condition is due to Rh, ABO, or other blood group incompatibility when documented.